Monitra Health, based in Hyderabad, India, is excited to share the accomplishment of concluding its Pre-Series A funding cycle, securing a substantial investment of $1.5 million. Key investors such as Equanimity Ventures and Kotak Alternate Asset Managers contributed significantly to this round. The influx of funds is intended to propel the advancement of Monitra Health's innovative upBeat remote cardiac monitoring platform, strategically tailored to serve both domestic and international markets.

Monitra Health stands out in its sector by introducing upBeat, India's pioneering comprehensive remote cardiac monitoring platform, designed specifically for scalable implementation. Recognized for its advanced features, upBeat assists in diagnosing unexplained fainting, dizziness, and palpitations, earning notable recognition among healthcare professionals like cardiac electrophysiologists, cardiologists, neurologists and MD physicians. Its exceptional tracing accuracy and superior reporting capabilities distinguish it within the industry.

Ravi Bhogu, the CEO and Founder of Monitra Health, conveyed his excitement, stating, "We are delighted to announce the successful completion of our Pre-Series A funding round of USD 1.5 million led by Equanimity Ventures and Kotak. This achievement drives our global initiative to redefine continuous cardiac monitoring with upBeat, our leading-edge flagship product renowned for its precision and exceptional reporting".